Home > Drug Search >
  • company_query: Aventis
  •   > 
Drug Filter
Category:
chemistry (16) biology (48)
Status:
Approved (1) Withdrawn (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (23) Phase Ⅰ (32) IND Filing (1)
Clinical Stage:
Pending (11) Active (34) Discontinued (16)
Bio-Type:
Gene therapy (1) Vaccine (38) Recombinant coagulation factor (1) Recombinant hormone (1) Whole antibody (3) Fab fragment (1) ADC (1) Fusion protein (1)
Indication:
Alzheimer's disease (AD) (2) Poisoning (1) Avian influenza (1) Depression (1) Herpes simplex virus (2) Duchenne muscular dystrophy (DMD) (1) Cytomegalovirus infections (1) HIV infection (14) Hypertension (1) Influenza virus infection (4) Major depressive disorder (MDD) (1) Multiple myeloma (MM) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Obesity (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Rheumatoid arthritis (RA) (1) Sjoegren's syndrome (1) Solid tumours (2) Rotavirus infection (1) Peanut hypersensitivity (1) Tuberculosis (1) Type 2 diabetes (1) Yellow fever (1) Vaginitis (1) Coronavirus infection (1) Influenza A virus infections (1) Colorectal cancer (1) Cirrhosis (1) Chronic heart failure (1) Malaria (5) Type 1 diabetes (1) Portal hypertension (1) Acute heart failure (1) Enteric infections (1) Thrombosis (1) Alopecia (1) Coronary heart disease (1) Respiratory syncytial virus infection (2) Dengue fever (1) Ebola virus disease (EVD) (5)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top